GSK: Target Identification Mechanism for Bispecific Antibodies

Funder (GSK) is interested in discovering if there are methods  by which we can (i) predict the ability of any given target pair to act synergistically, and within this space (ii) predict target combinations that might be uniquely suitable to modulation by a BsAb, and create medicines with the potential to be more efficacious than the equivalent mAb combination therapy. Funding and length undisclosed.

https://www.innocentive.com/ar/challenge/9933655